New hope for Parkinson's pain: drug trial targets tough-to-treat discomfort
NCT ID NCT07483398
First seen Mar 23, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This study tests whether a drug called crisugabalin can safely reduce pain in people with Parkinson's disease. About 166 adults will take either the drug or a placebo for 12 weeks, and researchers will track their pain levels and any side effects. The goal is to find a better way to ease pain that doesn't respond to usual treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE WITH NOCICEPTIVE PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
No. 106 Zhongshan Er Road
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.